SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052197
Filing Date
2020-11-09
Accepted
2020-11-09 07:40:58
Documents
79
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q urgn-10q_20200930.htm   iXBRL 10-Q 2411638
2 EX-10.3 urgn-ex103_48.htm EX-10.3 125397
3 EX-10.4 urgn-ex104_51.htm EX-10.4 18306
4 EX-31.1 urgn-ex311_8.htm EX-31.1 19228
5 EX-31.2 urgn-ex312_7.htm EX-31.2 19258
6 EX-32.1 urgn-ex321_6.htm EX-32.1 9735
7 EX-32.2 urgn-ex322_9.htm EX-32.2 9747
  Complete submission text file 0001564590-20-052197.txt   7791563

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA urgn-20200930.xsd EX-101.SCH 57259
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20200930_cal.xml EX-101.CAL 46871
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20200930_def.xml EX-101.DEF 128676
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20200930_lab.xml EX-101.LAB 386032
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20200930_pre.xml EX-101.PRE 283019
13 EXTRACTED XBRL INSTANCE DOCUMENT urgn-10q_20200930_htm.xml XML 1270190
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 201296120
SIC: 2834 Pharmaceutical Preparations